88 related articles for article (PubMed ID: 15074002)
1. DKK1 in multiple myeloma.
Hofbauer LC; Neubauer A; Schoppet M
N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15074002
[No Abstract] [Full Text] [Related]
2. DKK1 in multiple myeloma.
Lu CM
N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15074001
[No Abstract] [Full Text] [Related]
3. Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cells.
Giuliani N; Colla S; Morandi F; Barille-Nion S; Rizzoli V
Haematologica; 2005 Feb; 90(2):275-8. PubMed ID: 15710592
[TBL] [Abstract][Full Text] [Related]
4. Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cells.
Heider U; Zavrski I; Jakob C; Fleissner C; Sezer O
Cancer Res; 2004 Jan; 64(2):773-4; author reply 774-5. PubMed ID: 14744798
[No Abstract] [Full Text] [Related]
5. Multiple myeloma.
Schneider HG; Sentry J
N Engl J Med; 2005 Feb; 352(8):840-1; author reply 840-1. PubMed ID: 15736296
[No Abstract] [Full Text] [Related]
6. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
7. Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment?
Giuliani N; Colla S; Rizzoli V; Barillé-Nion S; Bataille R
Cancer Res; 2004 Jan; 64(2):772-3; author reply 774-5. PubMed ID: 14744797
[No Abstract] [Full Text] [Related]
8. DKK1 in multiple myeloma.
Meyer MA
N Engl J Med; 2004 Apr; 350(14):1464-6; author reply 1464-6. PubMed ID: 15070800
[No Abstract] [Full Text] [Related]
9. Evolution of understanding of genetics of Paget's disease of bone and related diseases.
Takata S; Yasui N; Nakatsuka K; Ralston SH
J Bone Miner Metab; 2004; 22(6):519-23. PubMed ID: 15490260
[No Abstract] [Full Text] [Related]
10. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
11. Bone lesions in molecular subtypes of multiple myeloma.
Robbiani DF; Chesi M; Bergsagel PL
N Engl J Med; 2004 Jul; 351(2):197-8. PubMed ID: 15247367
[No Abstract] [Full Text] [Related]
12. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
Tian E; Zhan F; Walker R; Rasmussen E; Ma Y; Barlogie B; Shaughnessy JD
N Engl J Med; 2003 Dec; 349(26):2483-94. PubMed ID: 14695408
[TBL] [Abstract][Full Text] [Related]
13. Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus.
Farach-Carson MC; Bergh JJ; Xu Y
Steroids; 2004 Aug; 69(8-9):543-7. PubMed ID: 15288767
[TBL] [Abstract][Full Text] [Related]
14. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
16. Update on the pathogenesis of osteolysis in multiple myeloma patients.
Giuliani N; Colla S; Rizzoli V
Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
[TBL] [Abstract][Full Text] [Related]
17. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
Nguyen AN; Stebbins EG; Henson M; O'Young G; Choi SJ; Quon D; Damm D; Reddy M; Ma JY; Haghnazari E; Kapoun AM; Medicherla S; Protter A; Schreiner GF; Kurihara N; Anderson J; Roodman GD; Navas TA; Higgins LS
Exp Cell Res; 2006 Jun; 312(10):1909-23. PubMed ID: 16600214
[TBL] [Abstract][Full Text] [Related]
18. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
[TBL] [Abstract][Full Text] [Related]
19. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
[TBL] [Abstract][Full Text] [Related]
20. Functional osteoclast-like transformation of cultured human myeloma cell lines.
Calvani N; Cafforio P; Silvestris F; Dammacco F
Br J Haematol; 2005 Sep; 130(6):926-38. PubMed ID: 16156862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
